Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

ChromoGenics

Less than 1K followers
All
Press releases
3rd party
ShowingAll content types
Regulatory press release9/16/2024, 2:45 PM

Avnotering av ChromoGenics AB (publ) från Nasdaq First North Stockholm

ChromoGenics
Regulatory press release9/16/2024, 2:45 PM

Avnotering av ChromoGenics AB (publ) från Nasdaq First North Stockholm

ChromoGenics
Regulatory press release9/13/2024, 12:00 PM

ChromoGenics AB (publ): Färna Invest AB påkallar tvångsinlösen och ChromoGenics ansöker om avnotering

ChromoGenics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release9/13/2024, 12:00 PM

ChromoGenics AB (publ): Färna Invest AB påkallar tvångsinlösen och ChromoGenics ansöker om avnotering

ChromoGenics
Regulatory press release8/30/2024, 6:30 AM

ChromoGenics AB (publ): ChromoGenics delårsrapport Januari-Juni 2024

ChromoGenics
Regulatory press release8/30/2024, 6:30 AM

ChromoGenics AB (publ): ChromoGenics Interim Report January-June 2024

ChromoGenics
Regulatory press release6/25/2024, 11:45 AM

ChromoGenics AB (publ): Bulletin from the annual general meeting held on 25 June 2024

ChromoGenics
Regulatory press release6/25/2024, 11:45 AM

ChromoGenics AB (publ): Kommuniké från årsstämman den 25 juni 2024

ChromoGenics
Regulatory press release6/18/2024, 2:30 PM

ChromoGenics AB (publ) publicerar årsredovisningen för 2023

ChromoGenics
Regulatory press release6/18/2024, 2:30 PM

ChromoGenics AB (publ) publishes the Annual Report for 2023

ChromoGenics
Regulatory press release5/30/2024, 11:00 AM

ChromoGenics AB (publ): ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant

ChromoGenics
Regulatory press release5/30/2024, 11:00 AM

ChromoGenics AB (publ): ChromoGenics meddelar att villkorslån på 47,6 MSEK omvandlas till bidrag

ChromoGenics
Regulatory press release5/24/2024, 7:00 AM

ChromoGenics AB (publ): NOTICE TO ANNUAL GENERAL MEETING IN CHROMOGENICS AB

ChromoGenics
Regulatory press release5/24/2024, 7:00 AM

ChromoGenics AB (publ): KALLELSE TILL ÅRSSTÄMMA I CHROMOGENICS AB

ChromoGenics
Regulatory press release5/23/2024, 1:30 PM

ChromoGenics AB (publ): ChromoGenics styrelse stödjer Färna invests uppköpserbjudande

ChromoGenics
Regulatory press release5/23/2024, 6:30 AM

ChromoGenics AB (publ): Interim Report January - March 2024

ChromoGenics
Regulatory press release5/23/2024, 6:30 AM

ChromoGenics AB (publ): Delårsrapport januari-mars 2024

ChromoGenics
Regulatory press release4/8/2024, 5:00 PM

ChromoGenics AB (publ): ChromoGenics announces new date for its annual general meeting and annual report 2023

ChromoGenics
Regulatory press release4/8/2024, 5:00 PM

ChromoGenics AB (publ): ChromoGenics meddelar nytt datum för årsstämma & årsredovisning 2023

ChromoGenics
Regulatory press release4/5/2024, 1:30 PM

ChromoGenics AB (publ) announces allocation in directed share issue

ChromoGenics
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.